<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38359818</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.16330</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">The post-acute sequelae of SARS-CoV-2 infection pose a significant global challenge, with nearly 50% of critical COVID-19 survivors manifesting persistent lung abnormalities. The lack of understanding about the molecular mechanisms and effective treatments hampers their management. Here, we employed microRNA (miRNA) profiling to decipher the systemic molecular underpinnings of the persistent pulmonary complications.</AbstractText><AbstractText Label="EXPERIMENTAL APPROACH" NlmCategory="METHODS">We conducted a longitudinal investigation including 119 critical COVID-19 survivors. A comprehensive pulmonary evaluation was performed in the short-term (median&#x2009;=&#x2009;94.0&#xa0;days after hospital discharge) and long-term (median&#x2009;=&#x2009;358&#x2009;days after hospital discharge). Plasma miRNAs were quantified at the short-term evaluation using the gold-standard technique, RT-qPCR. The analyses combined machine learning feature selection techniques with bioinformatic investigations. Two additional datasets were incorporated for validation.</AbstractText><AbstractText Label="KEY RESULTS" NlmCategory="RESULTS">In the short-term, 84% of the survivors exhibited impaired lung diffusion (D<sub>LCO</sub> &#xa0;&lt;&#x2009;80% of predicted). One year post-discharge, 54.4% of this patient subgroup still presented abnormal D<sub>LCO</sub> . Four feature selection methods identified two specific miRNAs, miR-9-5p and miR-486-5p, linked to persistent lung dysfunction. The downstream experimentally validated targetome included 1473 genes, with heterogeneous enriched pathways associated with inflammation, angiogenesis and cell senescence. Validation studies using RNA-sequencing and proteomic datasets emphasized the pivotal roles of cell migration and tissue repair in persistent lung dysfunction. The repositioning potential of the miRNA targets was limited.</AbstractText><AbstractText Label="CONCLUSION AND IMPLICATIONS" NlmCategory="CONCLUSIONS">Our study reveals early mechanistic pathways contributing to persistent lung dysfunction in critical COVID-19 survivors, offering a promising approach for the development of targeted disease-modifying agents.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Hidalgo</LastName><ForeName>Mar&#xed;a C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben&#xed;tez</LastName><ForeName>Iv&#xe1;n D</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Pons</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molinero</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belmonte</LastName><ForeName>Thal&#xed;a</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Mu&#xf1;oz</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguil&#xe0;</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santisteve</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Gerard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Precision Medicine in Chronic Diseases, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moncus&#xed;-Moix</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Group of Precision Medicine in Chronic Diseases, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gort-Paniello</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pel&#xe1;ez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomarkers and Molecular Signaling Group, Neurodegenerative Diseases Area Center for Biomedical Research of La Rioja, CIBIR, Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larr&#xe1;yoz</LastName><ForeName>Ignacio M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Biomarkers and Molecular Signaling Group, Neurodegenerative Diseases Area Center for Biomedical Research of La Rioja, CIBIR, Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIAS, Department of Nursing, University of La Rioja, Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caballero</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grup de Recerca Medicina Intensiva, Intensive Care Department Hospital Universitari Arnau de Vilanova, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barber&#xe0;</LastName><ForeName>Carme</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Department, University Hospital Santa Mar&#xed;a, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nova-Lamperti</LastName><ForeName>Estefania</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepcion, Concepcion, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Clinic Institute of Thorax (ICT), Hospital Clinic of Barcelona, Insitut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), ICREA, University of Barcelona (UB), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barb&#xe9;</LastName><ForeName>Ferran</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Gonzalo-Calvo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Universitat de Lleida</Agency><Country/></Grant><Grant><Agency>Fundaci&#xf3;n Francisco Soria Melguizo</Agency><Country/></Grant><Grant><GrantID>COV20/00110</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>CP20/00041</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>CPII20/00029</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>FI21/00187</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>FI21/00187</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><Agency>Societat Catalana de Pneumologia</Agency><Country/></Grant><Grant><GrantID>SLT028/23/000191</GrantID><Agency>Departament de Salut, Generalitat de Catalunya</Agency><Country/></Grant><Grant><GrantID>SLT028/23/000191</GrantID><Agency>Departament de Salut, Generalitat de Catalunya</Agency><Country/></Grant><Grant><Agency>Programa de donaciones "Estar preparados" UNESPA</Agency><Country/></Grant><Grant><GrantID>1222/2022</GrantID><Agency>Sociedad Espa&#xf1;ola de Neumolog&#xed;a y Cirug&#xed;a Tor&#xe1;cica</Agency><Country/></Grant><Grant><GrantID>1437/2023</GrantID><Agency>Sociedad Espa&#xf1;ola de Neumolog&#xed;a y Cirug&#xed;a Tor&#xe1;cica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">drug discovery</Keyword><Keyword MajorTopicYN="N">drug repositioning</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lung dysfunction</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 sequelae</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>18</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38359818</ArticleId><ArticleId IdType="doi">10.1111/bph.16330</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>B&#xe4;r, C., Thum, T., &amp; de Gonzalo-Calvo, D. (2019). Circulating miRNAs as mediators in cell-to-cell communication. Epigenomics, 11, 111-113. https://doi.org/10.2217/epi-2018-0183</Citation></Reference><Reference><Citation>Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M., &amp; Dahlsveen, I. K. (2013). Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods, 59, S1-S6. https://doi.org/10.1016/j.ymeth.2012.09.015</Citation></Reference><Reference><Citation>Bonneau, E., Neveu, B., Kostantin, E., Tsongalis, G. J., &amp; De Guire, V. (2019). How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC, 30, 114-127.</Citation></Reference><Reference><Citation>Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., Fein, A., Heffner, J., Lareau, S., Meek, P., Martinez, F., McNicholas, W., Muris, J., Austegard, E., Pauwels, R., &#x2026; ZuWallack, R. (2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal, 23, 932-946. https://doi.org/10.1183/09031936.04.00014304</Citation></Reference><Reference><Citation>Chioccioli, M., Roy, S., Newell, R., Pestano, L., Dickinson, B., Rigby, K., Herazo-Maya, J., Jenkins, G., Ian, S., Saini, G., Johnson, S. R., Braybrooke, R., Yu, G., Sauler, M., Ahangari, F., Ding, S., DeIuliis, J., Aurelien, N., Montgomery, R. L., &amp; Kaminski, N. (2022). A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis. eBioMedicine, 85, 104304. https://doi.org/10.1016/j.ebiom.2022.104304</Citation></Reference><Reference><Citation>Curtis, M. J., Alexander, S. P. H., Cirino, G., George, C. H., Kendall, D. A., Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Patel, H. H., Sobey, C. G., Stanford, S. C., Stanley, P., Stefanska, B., Stephens, G. J., Teixeira, M. M., Vergnolle, N., &amp; Ahluwalia, A. (2022). Planning experiments: Updated guidance on experimental design and analysis and their reporting III. British Journal of Pharmacology, 179, 3907-3913. https://doi.org/10.1111/bph.15868</Citation></Reference><Reference><Citation>Dragomir, M. P., Fuentes-Mattei, E., Winkle, M., Okubo, K., Bayraktar, R., Knutsen, E., Qdaisat, A., Chen, M., Li, Y., Shimizu, M., Pang, L., Liu, K., Liu, X., Anfossi, S., Zhang, H., Koch, I., Tran, A. M., Mohapatra, S., Ton, A., &#x2026; Calin, G. A. (2023). Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. The Journal of Clinical Investigation, 133, e158348. https://doi.org/10.1172/JCI158348</Citation></Reference><Reference><Citation>Errington, N., Iremonger, J., Pickworth, J. A., Kariotis, S., Rhodes, C. J., Rothman, A. M., Condliffe, R., Elliot, C. A., Kiely, D. G., Howard, L. S., Wharton, J., Thompson, A. A. R., Morrell, N. W., Wilkins, M. R., Wang, D., &amp; Lawrie, A. (2021). A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. eBioMedicine, 69, 103444. https://doi.org/10.1016/j.ebiom.2021.103444</Citation></Reference><Reference><Citation>Fierro-Fern&#xe1;ndez, M., Busnadiego, &#xd3;., Sandoval, P., Espinosa-D&#xed;ez, C., Blanco-Ruiz, E., Rodr&#xed;guez, M., Pian, H., Ramos, R., L&#xf3;pez-Cabrera, M., Garc&#xed;a-Bermejo, M. L., &amp; Lamas, S. (2015). miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. EMBO Reports, 16, 1358-1377. https://doi.org/10.15252/embr.201540750</Citation></Reference><Reference><Citation>Foinquinos, A., Batkai, S., Genschel, C., Viereck, J., Rump, S., Gy&#xf6;ngy&#xf6;si, M., Traxler, D., Riesenhuber, M., Spannbauer, A., Lukovic, D., Weber, N., Zlabinger, K., Ha&#x161;imbegovi&#x107;, E., Winkler, J., Fiedler, J., Dangwal, S., Fischer, M., De la Roche, J., Wojciechowski, D., &#x2026; Thum, T. (2020). Preclinical development of a miR-132 inhibitor for heart failure treatment. Nature Communications, 11, 633. https://doi.org/10.1038/s41467-020-14349-2</Citation></Reference><Reference><Citation>Fonti, V., &amp; Belitser, E. (2017). Feature Selection using LASSO.</Citation></Reference><Reference><Citation>Freshour, S. L., Kiwala, S., Cotto, K. C., Coffman, A. C., McMichael, J. F., Song, J. J., Griffith, M., Griffith, O. L., &amp; Wagner, A. H. (2021). Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Research, 49, D1144-D1151. https://doi.org/10.1093/nar/gkaa1084</Citation></Reference><Reference><Citation>Garc&#xed;a-Hidalgo, M. C., Gonz&#xe1;lez, J., Ben&#xed;tez, I. D., Carmona, P., Santisteve, S., Moncus&#xed;-Moix, A., Gort-Paniello, C., Rodr&#xed;guez-Jara, F., Molinero, M., Perez-Pons, M., Torres, G., Caballero, J., Barber&#xe0;, C., Tedim, A. P., Almansa, R., Ceccato, A., Fern&#xe1;ndez-Barat, L., Ferrer, R., Garcia-Gasulla, D., &#x2026; CIBERESUCICOVID Project (COV20/00110, ISCIII). (2022). Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS. Clinical and Translational Medicine, 12, e838. https://doi.org/10.1002/ctm2.838</Citation></Reference><Reference><Citation>Garc&#xed;a-Hidalgo, M. C., Gonz&#xe1;lez, J., Ben&#xed;tez, I. D., Carmona, P., Santisteve, S., P&#xe9;rez-Pons, M., Moncus&#xed;-Moix, A., Gort-Paniello, C., Rodr&#xed;guez-Jara, F., Molinero, M., Belmonte, T., Torres, G., Labarca, G., Nova-Lamperti, E., Caballero, J., Bermejo-Martin, J. F., Ceccato, A., Fern&#xe1;ndez-Barat, L., Ferrer, R., &#x2026; on behalf of the CIBERESUCICOVID Project (COV20/00110, ISCIII). (2022). Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS. Emerging Microbes &amp; Infections, 11, 1537-1549. https://doi.org/10.1080/22221751.2022.2081615</Citation></Reference><Reference><Citation>Garc&#xed;a-Hidalgo, M. C., Pel&#xe1;ez, R., Gonz&#xe1;lez, J., Santisteve, S., Ben&#xed;tez, I. D., Molinero, M., Perez-Pons, M., Belmonte, T., Torres, G., Moncus&#xed;-Moix, A., Gort-Paniello, C., Aguil&#xe0;, M., Seck, F., Carmona, P., Caballero, J., Barber&#xe0;, C., Ceccato, A., Fern&#xe1;ndez-Barat, L., Ferrer, R., &#x2026; Larr&#xe1;yoz, I. M. (2022). Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS-secondary to SARS-CoV-2 infection. Biomedicine &amp; Pharmacotherapy, 154, 113617. https://doi.org/10.1016/j.biopha.2022.113617</Citation></Reference><Reference><Citation>Garcia-Moreno, A., &amp; Carmona-Saez, P. (2020). Computational methods and software tools for functional analysis of miRNA data. Biomolecules, 10, 1252. https://doi.org/10.3390/biom10091252</Citation></Reference><Reference><Citation>Genuer, R., Poggi, J.-M., &amp; Tuleau-Malot, C. (2015). VSURF: An R package for variable selection using random forests. The R Journal, 7, 19. https://doi.org/10.32614/RJ-2015-018</Citation></Reference><Reference><Citation>George, P. M., Reed, A., Desai, S. R., Devaraj, A., Faiez, T. S., Laverty, S., Kanwal, A., Esneau, C., Liu, M. K. C., Kamal, F., Man, W. D. C., Kaul, S., Singh, S., Lamb, G., Faizi, F. K., Schuliga, M., Read, J., Burgoyne, T., Pinto, A. L., &#x2026; Singanayagam, A. (2022). A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae. Science Translational Medicine, 14, eabo5795. https://doi.org/10.1126/scitranslmed.abo5795</Citation></Reference><Reference><Citation>de Gonzalo-Calvo, D., Ben&#xed;tez, I. D., Pinilla, L., Carratal&#xe1;, A., Moncus&#xed;-Moix, A., Gort-Paniello, C., Molinero, M., Gonz&#xe1;lez, J., Torres, G., Bernal, M., Pico, S., Almansa, R., Jorge, N., Ortega, A., Bustamante-Munguira, E., G&#xf3;mez, J. M., Gonz&#xe1;lez-Rivera, M., Micheloud, D., Ryan, P., &#x2026; CIBERESUCICOVID Project (COV20/00110, ISCIII). (2021). Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Translational Research, 236, 147-159. https://doi.org/10.1016/j.trsl.2021.05.004</Citation></Reference><Reference><Citation>de Gonzalo-Calvo, D., Molinero, M., Ben&#xed;tez, I. D., Perez-Pons, M., Garc&#xed;a-Mateo, N., Ortega, A., Postigo, T., Garc&#xed;a-Hidalgo, M. C., Belmonte, T., Rodr&#xed;guez-Mu&#xf1;oz, C., Gonz&#xe1;lez, J., Torres, G., Gort-Paniello, C., Moncus&#xed;-Moix, A., Estella, &#xc1;., Tamayo Lomas, L., Mart&#xed;nez de la G&#xe1;ndara, A., Socias, L., Pe&#xf1;asco, Y., &#x2026; Barb&#xe9;, F. (2023). A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: A multicenter validation study. Respiratory Research, 24, 159. https://doi.org/10.1186/s12931-023-02462-x</Citation></Reference><Reference><Citation>Gonz&#xe1;lez, J., Ben&#xed;tez, I. D., Carmona, P., Santisteve, S., Monge, A., Moncus&#xed;-Moix, A., Gort-Paniello, C., Pinilla, L., Carratal&#xe1;, A., Zuil, M., Ferrer, R., Ceccato, A., Fern&#xe1;ndez, L., Motos, A., Riera, J., Men&#xe9;ndez, R., Garcia-Gasulla, D., Pe&#xf1;uelas, O., Bermejo-Martin, J. F., &#x2026; Trenado, J. (2021). Pulmonary function and radiologic features in survivors of critical COVID-19: A 3-month prospective cohort. Chest, 160, 187-198. https://doi.org/10.1016/J.CHEST.2021.02.062</Citation></Reference><Reference><Citation>Gonz&#xe1;lez, J., Zuil, M., Ben&#xed;tez, I. D., de Batlle, J., Aguil&#xe0;, M., Santisteve, S., Varvar&#xe1;, N., Monge, A., Forns, N., Vaca, R., Minguez, O., Seck, F., Gort-Paniello, C., Moncus&#xed;-Moix, A., Caballero, J., Barber&#xe0;, C., De Gonzalo-Calvo, D., Torres, A., Barb&#xe9;, F., &amp; CIBERESUCICOVID Project (COV20/00110, ISCIII). (2023). Long-term outcomes in critical COVID-19 survivors: A 2-year longitudinal cohort. Archivos de Bronconeumolog&#xed;a, 59, 691-697. https://doi.org/10.1016/j.arbres.2023.08.006</Citation></Reference><Reference><Citation>Gonz&#xe1;lez, J., Zuil, M., Ben&#xed;tez, I. D., de Gonzalo-Calvo, D., Aguilar, M., Santisteve, S., Vaca, R., Minguez, O., Seck, F., Torres, G., De Batlle, J., G&#xf3;mez, S., Barril, S., Moncus&#xed;-Moix, A., Monge, A., Gort-Paniello, C., Ferrer, R., Ceccato, A., Fern&#xe1;ndez, L., &#x2026; Barb&#xe9;, F. (2022). One year overview and follow-up in a post-COVID consultation of critically ill patients. Frontiers in Medicine, 9, 897990. https://doi.org/10.3389/FMED.2022.897990</Citation></Reference><Reference><Citation>Herridge, M. S., Cheung, A. M., Tansey, C. M., Matte-Martyn, A., Diaz-Granados, N., al-Saidi, F., Cooper, A. B., Guest, C. B., Mazer, C. D., Mehta, S., Stewart, T. E., Barr, A., Cook, D., &amp; Slutsky, A. S. (2003). One-year outcomes in survivors of the acute respiratory distress syndrome. New England Journal of Medicine, 348, 683-693. https://doi.org/10.1056/nejmoa022450</Citation></Reference><Reference><Citation>Hong, D. S., Kang, Y.-K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J. L., Kim, T. Y., Shin, S., Becerra, C. R., Falchook, G., Stoudemire, J., Martin, D., Kelnar, K., Peltier, H., Bonato, V., Bader, A. G., &#x2026; Beg, M. S. (2020). Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. British Journal of Cancer, 122, 1630-1637. https://doi.org/10.1038/s41416-020-0802-1</Citation></Reference><Reference><Citation>Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., Van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., Persson, R., King, B. D., Kauppinen, S., Levin, A. A., &amp; Hodges, M. R. (2013). Treatment of HCV infection by targeting microRNA. The New England Journal of Medicine, 368, 1685-1694. https://doi.org/10.1056/NEJMoa1209026</Citation></Reference><Reference><Citation>Ji, X., Wu, B., Fan, J., Han, R., Luo, C., Wang, T., Yang, J., Han, L., Zhu, B., Wei, D., Chen, J., &amp; Ni, C. (2015). The anti-fibrotic effects and mechanisms of MicroRNA-486-5p in pulmonary fibrosis. Scientific Reports, 5, 14131. https://doi.org/10.1038/srep14131</Citation></Reference><Reference><Citation>Jouan, Y., Baranek, T., Si-Tahar, M., Paget, C., &amp; Guillon, A. (2021). Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS. Critical Care, 25, 120. https://doi.org/10.1186/s13054-021-03513-9</Citation></Reference><Reference><Citation>Jusic, A., Thomas, P. B., Wettinger, S. B., Dogan, S., Farrugia, R., Gaetano, C., Tuna, B. G., Pinet, F., Robinson, E. L., Tual-Chalot, S., Stellos, K., Devaux, Y., &amp; EU-CardioRNA COST Action CA17129. (2022). Noncoding RNAs in age-related cardiovascular diseases. Ageing Research Reviews, 77, 101610. https://doi.org/10.1016/j.arr.2022.101610</Citation></Reference><Reference><Citation>Karagkouni, D., Paraskevopoulou, M. D., Chatzopoulos, S., Vlachos, I. S., Tastsoglou, S., Kanellos, I., Papadimitriou, D., Kavakiotis, I., Maniou, S., Skoufos, G., Vergoulis, T., Dalamagas, T., &amp; Hatzigeorgiou, A. G. (2018). DIANA-TarBase v8: A decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Research, 46, D239-D245. https://doi.org/10.1093/nar/gkx1141</Citation></Reference><Reference><Citation>Kerksieck, P., Ballouz, T., Haile, S. R., Schumacher, C., Lacy, J., Domenghino, A., Bauer, G. F., Dressel, H., Puhan, M. A., &amp; Menges, D. (2023). Post COVID-19 condition, work ability and occupational changes in a population-based cohort. The Lancet Regional Health Europe, 31, 100671. https://doi.org/10.1016/J.LANEPE.2023.100671</Citation></Reference><Reference><Citation>Kursa, M. B., &amp; Rudnicki, W. R. (2010). Feature selection with the Boruta package. Journal of Statistical Software, 36, 1-13. https://doi.org/10.18637/jss.v036.i11</Citation></Reference><Reference><Citation>L&#xea; Cao, K.-A., Rossouw, D., Robert-Grani&#xe9;, C., &amp; Besse, P. (2008). A sparse PLS for variable selection when integrating omics data. Statistical Applications in Genetics and Molecular Biology, 7, 35. https://doi.org/10.2202/1544-6115.1390</Citation></Reference><Reference><Citation>Li, J., Salvador, A. M., Li, G., Valkov, N., Ziegler, O., Yeri, A., Yang Xiao, C., Meechoovet, B., Alsop, E., Rodosthenous, R. S., Kundu, P., Huan, T., Levy, D., Tigges, J., Pico, A. R., Ghiran, I., Silverman, M. G., Meng, X., Kitchen, R., &#x2026; das, S. (2021). Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling. Circulation Research, 128, e1-e23. https://doi.org/10.1161/CIRCRESAHA.120.317244</Citation></Reference><Reference><Citation>Li, J., Zhou, Q., Liang, Y., Pan, W., Bei, Y., Zhang, Y., Wang, J., &amp; Jiao, Z. (2018). miR-486 inhibits PM2.5-induced apoptosis and oxidative stress in human lung alveolar epithelial A549 cells. Annals of Translational Medicine, 6, 209. https://doi.org/10.21037/atm.2018.06.09</Citation></Reference><Reference><Citation>Love, M. I., Huber, W., &amp; Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15, 550. https://doi.org/10.1186/s13059-014-0550-8</Citation></Reference><Reference><Citation>Luo, Q., Zhu, J., Zhang, Q., Xie, J., Yi, C., &amp; Li, T. (2020). MicroRNA-486-5p promotes acute lung injury via inducing inflammation and apoptosis by targeting OTUD7B. Inflammation, 43, 975-984. https://doi.org/10.1007/s10753-020-01183-3</Citation></Reference><Reference><Citation>Makkos, A., &#xc1;gg, B., Petrovich, B., Varga, Z. V., G&#xf6;rbe, A., &amp; Ferdinandy, P. (2021). Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia/reperfusion injury and infarction: Involvement of redox signalling. Free Radical Biology &amp; Medicine, 172, 237-251. https://doi.org/10.1016/j.freeradbiomed.2021.04.034</Citation></Reference><Reference><Citation>Mart&#xed;n-Vicente, P., L&#xf3;pez-Mart&#xed;nez, C., Lopez-Alonso, I., L&#xf3;pez-Aguilar, J., Albaiceta, G. M., &amp; Amado-Rodr&#xed;guez, L. (2021). Molecular mechanisms of postintensive care syndrome. Intensive Care Medicine Experimental, 9, 58. https://doi.org/10.1186/s40635-021-00423-6</Citation></Reference><Reference><Citation>Molinero, M., Ben&#xed;tez, I. D., Gonz&#xe1;lez, J., Gort-Paniello, C., Moncus&#xed;-Moix, A., Rodr&#xed;guez-Jara, F., Garc&#xed;a-Hidalgo, M. C., Torres, G., Vengoechea, J. J., G&#xf3;mez, S., Cabo, R., Caballero, J., Bermejo-Martin, J. F., Ceccato, A., Fern&#xe1;ndez-Barat, L., Ferrer, R., Garcia-Gasulla, D., Men&#xe9;ndez, R., Motos, A., &#x2026; De Gonzalo-Calvo, D. (2022). Bronchial aspirate-based profiling identifies MicroRNA signatures associated with COVID-19 and fatal disease in critically ill patients. Frontiers in Medicine, 8, 756517. https://doi.org/10.3389/fmed.2021.756517</Citation></Reference><Reference><Citation>Molinero, M., G&#xf3;mez, S., Ben&#xed;tez, I. D., Vengoechea, J. J., Gonz&#xe1;lez, J., Polanco, D., Gort-Paniello, C., Moncus&#xed;-Moix, A., Garc&#xed;a-Hidalgo, M. C., Perez-Pons, M., Belmonte, T., Torres, G., Caballero, J., Barber&#xe0;, C., Ayestar&#xe1;n Rota, J. I., Soc&#xed;as Cresp&#xed;, L., Ceccato, A., Fern&#xe1;ndez-Barat, L., Ferrer, R., &#x2026; De Gonzalo-Calvo, D. (2022). Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection. Frontiers in Immunology, 13, 942443. https://doi.org/10.3389/fimmu.2022.942443</Citation></Reference><Reference><Citation>Mylvaganam, R. J., Bailey, J. I., Sznajder, J. I., &amp; Sala, M. A. (2021). Recovering from a pandemic: Pulmonary fibrosis after SARS-CoV-2 infection. European Respiratory Review, 30, 210194. https://doi.org/10.1183/16000617.0194-2021</Citation></Reference><Reference><Citation>Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., Ahluwalia, N., Bikdeli, B., Dietz, D., der-Nigoghossian, C., Liyanage-Don, N., Rosner, G. F., Bernstein, E. J., Mohan, S., Beckley, A. A., &#x2026; Wan, E. Y. (2021). Post-acute COVID-19 syndrome. Nature Medicine, 27, 601-615. https://doi.org/10.1038/s41591-021-01283-z</Citation></Reference><Reference><Citation>Pastor-Fern&#xe1;ndez, A., Bertos, A. R., Sierra-Ram&#xed;rez, A., del Moral-Salmoral, J., Merino, J., de &#xc1;vila, A. I., Olag&#xfc;e, C., Villares, R., Gonz&#xe1;lez-Aseguinolaza, G., Rodr&#xed;guez, M. &#xc1;., Fresno, M., Giron&#xe9;s, N., Bustos, M., Smerdou, C., Fernandez-Marcos, P. J., &amp; Von Kobbe, C. (2023). Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging Cell, 22, e13771. https://doi.org/10.1111/ACEL.13771</Citation></Reference><Reference><Citation>Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., Van Der Grinten, C. P., Gustafsson, P., Hankinson, J., &amp; Jensen, R. (2005). Interpretative strategies for lung function tests. European Respiratory Journal, 26, 948-968. https://doi.org/10.1183/09031936.05.00035205</Citation></Reference><Reference><Citation>Ranieri, V. M., Rubenfeld, G. D., Thompson, B. T., Ferguson, N. D., Caldwell, E., Fan, E., &amp; Camporota, L. (2012). Acute respiratory distress syndrome: The Berlin definition. JAMA: The Journal of the American Medical Association, 307, 2526-2533. https://doi.org/10.1001/jama.2012.5669</Citation></Reference><Reference><Citation>Ravaglia, C., Doglioni, C., Chilosi, M., Piciucchi, S., Dubini, A., Rossi, G., Pedica, F., Puglisi, S., Donati, L., Tomassetti, S., &amp; Poletti, V. (2022). Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. The European Respiratory Journal, 60, 2102411. https://doi.org/10.1183/13993003.02411-2021</Citation></Reference><Reference><Citation>Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., &amp; Smyth, G. K. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43, e47. https://doi.org/10.1093/NAR/GKV007</Citation></Reference><Reference><Citation>Roca, J., Burgos, F., Sunyer, J., Saez, M., Chinn, S., Anto, J., Rodriguez-Roisin, R., Quanjer, P. H., Nowak, D., &amp; Burney, P. (1998). References values for forced spirometry. Group of the European Community Respiratory Health Survey. European Respiratory Journal, 11, 1354-1362. https://doi.org/10.1183/09031936.98.11061354</Citation></Reference><Reference><Citation>Rupani, H., Sanchez-Elsner, T., &amp; Howarth, P. (2013). MicroRNAs and respiratory diseases. European Respiratory Journal, 41, 695-705. https://doi.org/10.1183/09031936.00212011</Citation></Reference><Reference><Citation>Schlemmer, F., Valentin, S., Boyer, L., Guillaumot, A., Chabot, F., Dupin, C., Le Guen, P., Lorillon, G., Bergeron, A., Basille, D., Delomez, J., Andrejak, C., Bonnefoy, V., Goussault, H., Assi&#xe9;, J. B., Choinier, P., Ruppert, A. M., Cadranel, J., Mennitti, M. C., &#x2026; RE2COVERI Study Group. (2023). Respiratory recovery trajectories after severe-to-critical COVID-19: A 1-year prospective multicentre study. European Respiratory Journal, 61, 2201532. https://doi.org/10.1183/13993003.01532-2022</Citation></Reference><Reference><Citation>Sibila, O., Perea, L., Albacar, N., Mois&#xe9;s, J., Cruz, T., Mendoza, N., Solarat, B., Lled&#xf3;, G., Espinosa, G., Barber&#xe0;, J. A., Badia, J. R., Agust&#xed;, A., Sellar&#xe9;s, J., &amp; Faner, R. (2022). Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respiratory Research, 23, 37. https://doi.org/10.1186/s12931-022-01955-5</Citation></Reference><Reference><Citation>Singh, S. J., Baldwin, M. M., Daynes, E., Evans, R. A., Greening, N. J., Jenkins, R. G., Lone, N. I., McAuley, H., Mehta, P., Newman, J., Novotny, P., Smith, D. J. F., Stanel, S., Toshner, M., &amp; Brightling, C. E. (2023). Respiratory sequelae of COVID-19: Pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. The Lancet Respiratory Medicine, 11, 709-725. https://doi.org/10.1016/S2213-2600(23)00159-5</Citation></Reference><Reference><Citation>Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., Doncheva, N. T., Legeay, M., Fang, T., Bork, P., Jensen, L. J., &amp; Von Mering, C. (2021). The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research, 49, 605-612. https://doi.org/10.1093/nar/gkaa1074</Citation></Reference><Reference><Citation>T&#xe4;ubel, J., Hauke, W., Rump, S., Viereck, J., Batkai, S., Poetzsch, J., Rode, L., Weigt, H., Genschel, C., Lorch, U., Theek, C., Levin, A. A., Bauersachs, J., Solomon, S. D., &amp; Thum, T. (2021). Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study. European Heart Journal, 42, 178-188. https://doi.org/10.1093/eurheartj/ehaa898</Citation></Reference><Reference><Citation>Torres, A., Arguimbau, M., Bermejo-Mart&#xed;n, J., Campo, R., Ceccato, A., Fernandez-Barat, L., Ferrer, R., Jarillo, N., Lorente-Balanza, J. &#xc1;., Men&#xe9;ndez, R., Motos, A., Mu&#xf1;oz, J., Pe&#xf1;uelas Rodr&#xed;guez, &#xd3;., P&#xe9;rez, R., Riera, J., Rodr&#xed;guez, A., S&#xe1;nchez, M., &amp; Barbe, F. (2021). CIBERESUCICOVID: Un proyecto estrat&#xe9;gico para una mejor comprensi&#xf3;n y manejo cl&#xed;nico de la COVID-19 en pacientes cr&#xed;ticos. Archivos de Bronconeumolog&#xed;a, 57, 1-2. https://doi.org/10.1016/J.ARBRES.2020.10.021</Citation></Reference><Reference><Citation>Valadi, H., Ekstr&#xf6;m, K., Bossios, A., Sj&#xf6;strand, M., Lee, J., &amp; L&#xf6;tvall, J. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9, 654-659. https://doi.org/10.1038/NCB1596</Citation></Reference><Reference><Citation>Vanhaverbeke, M., Attard, R., Bartekova, M., Ben-Aicha, S., Brandenburger, T., de Gonzalo-Calvo, D., Emanueli, C., Farrugia, R., Grillari, J., Hackl, M., Kalocayova, B., Martelli, F., Scholz, M., Wettinger, S. B., &amp; Devaux, Y. (2022). Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: A position paper from the EU-CardioRNA COST action CA17129. Cardiovascular Research, 118, 3183-3197. https://doi.org/10.1093/cvr/cvab327</Citation></Reference><Reference><Citation>Wang, X. (2020). Pleiotrophin: Activity and mechanism. Advances in Clinical Chemistry, 98, 51-89. https://doi.org/10.1016/bs.acc.2020.02.003</Citation></Reference><Reference><Citation>Wen, X., Zhang, H., Xiang, B., Zhang, W., Gong, F., Li, S., Chen, H., Luo, X., Deng, J., You, Y., Hu, Z., &amp; Jiang, C. (2021). Hyperoxia-induced miR-342-5p down-regulation exacerbates neonatal bronchopulmonary dysplasia via the Raf1 regulator Spred3. British Journal of Pharmacology, 178, 2266-2283. https://doi.org/10.1111/bph.15371</Citation></Reference><Reference><Citation>World Medical Association. (2013). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, 310(20), 2191-2194. https://doi.org/10.1001/jama.2013.281053</Citation></Reference><Reference><Citation>Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., Feng, T., Zhou, L., Tang, W., Zhan, L., Fu, X., Liu, S., Bo, X., &amp; Yu, G. (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation, 2, 100141. https://doi.org/10.1016/j.xinn.2021.100141</Citation></Reference><Reference><Citation>Ying, W., Gao, H., Dos Reis, F. C. G., Bandyopadhyay, G., Ofrecio, J. M., Luo, Z., Ji, Y., Jin, Z., Ly, C., &amp; Olefsky, J. M. (2021). MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice. Cell Metabolism, 33, 781-790.e5. https://doi.org/10.1016/j.cmet.2020.12.019</Citation></Reference><Reference><Citation>Zhang, Z., &amp; Cai, C. X. (2016). Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway. Molecular and Cellular Biochemistry, 416, 109-116. https://doi.org/10.1007/S11010-016-2700-7</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>